Intravenous nicardipine hydrochloride
1207M17921
Phase 3 small_molecule terminated
Quick answer
Intravenous nicardipine hydrochloride for Intracerebral Hemorrhage is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Intracerebral Hemorrhage
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated